YAZISIZ, V. Et Al. 2004. Clinical importance of antineutrophil cytoplasmic antibody positivity during propylthiouracil treatment. p.140, September 18-22, 2004. İstanbul. 30th Annual Meeting of the European Thyroid Association, , (İstanbul, Turkey), 140.

YAZISIZ, V., ÖNGÜT, G., & Karayalcin, Ü., (2004). Clinical importance of antineutrophil cytoplasmic antibody positivity during propylthiouracil treatment. p.140, September 18-22, 2004. İstanbul . 30th Annual Meeting of the European Thyroid Association, (pp.140). İstanbul, Turkey

YAZISIZ, VELİ, GÖZDE ÖNGÜT, And Ümit Karayalcin. "Clinical importance of antineutrophil cytoplasmic antibody positivity during propylthiouracil treatment. p.140, September 18-22, 2004. İstanbul," 30th Annual Meeting of the European Thyroid Association,, İstanbul, Turkey, 2004

YAZISIZ, VELİ Et Al. "Clinical importance of antineutrophil cytoplasmic antibody positivity during propylthiouracil treatment. p.140, September 18-22, 2004. İstanbul." 30th Annual Meeting of the European Thyroid Association, , İstanbul, Turkey, pp.140, 2004

YAZISIZ, V. ÖNGÜT, G. And Karayalcin, Ü. (2004) . "Clinical importance of antineutrophil cytoplasmic antibody positivity during propylthiouracil treatment. p.140, September 18-22, 2004. İstanbul." 30th Annual Meeting of the European Thyroid Association, , İstanbul, Turkey, p.140.

@conferencepaper{conferencepaper, author={VELİ YAZISIZ Et Al. }, title={Clinical importance of antineutrophil cytoplasmic antibody positivity during propylthiouracil treatment. p.140, September 18-22, 2004. İstanbul}, congress name={30th Annual Meeting of the European Thyroid Association,}, city={İstanbul}, country={Turkey}, year={2004}, pages={140} }